Reviving Extinct Species: The Partnership Between Colossal Biosciences and Viagen Pets and Equine
Former NFL quarterback Tom Brady recently shared that his pit bull mix, Junie, is actually a clone of his previous dog, Lua. The clone was created by the company Colossal Biosciences, in which Brady is an investor. Brady expressed his love for his pets and the importance they hold in his family. Colossal Biosciences, known for its de-extinction efforts, recently acquired Viagen Pets and Equine, a company specializing in animal cloning and genetic preservation. Viagen has successfully cloned various species and collected gene cultures of endangered animals, contributing to conservation efforts.
Colossal Biosciences made headlines earlier this year for bringing back the extinct dire wolf through genetic editing and cloning. While the company claims success in reviving extinct species, some experts remain skeptical about the full restoration of these animals. Despite the controversy, Colossal continues to advance its mission of de-extinction and species preservation. With Viagen's expertise and technology, the company aims to make significant contributions to global conservation efforts.
The collaboration between Colossal Biosciences and Viagen Pets and Equine signifies a significant step forward in genetic preservation and de-extinction research. By leveraging cutting-edge cloning technology and genetic editing, these companies are at the forefront of conservation efforts. The potential to revive extinct species and preserve endangered animals highlights the importance of innovative approaches in wildlife conservation. As the field of de-extinction continues to evolve, the partnership between Colossal and Viagen paves the way for groundbreaking advancements in genetic preservation and species restoration.